Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8

References

1. Ahn K., Angulo A., Ghazal P., Peterson P. A., Yang Y., Fruh K. 1996; Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proceedings of the National Academy of Sciences, USA 93:10990–10995
   [Google Scholar]
2. Andersson M., Paabo S., Nilsson T., Peterson P. A. 1985; Impaired intracellular transport of Class I MHC antigens as a possible means for adenovirus to evade immune surveillance. Cell 43:215–222
   [Google Scholar]
3. Arvanitakis L., Mesri E. A., Nador R. G., Said J. W., Asch A. S., Knowles D. M., Cesarman E. 1996; Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi’s sarcoma-associated herpesvirus (KHSV/HHV-8) in the absence of Epstein–Barr virus. Blood 88:2648–2654
   [Google Scholar]
4. Burgert H.-G., Kvist S. 1985; An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987–997
   [Google Scholar]
5. Campbell A. E., Slater J. S. 1994; Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. Journal of Virology 68:1805–1811
   [Google Scholar]
6. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. 1995; Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332:1186–1191
   [Google Scholar]
7. Coscoy L., Ganem D. 2000; Kaposi’s sarcoma associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proceedings of the National Academy of Sciences, USA 97:8051–8056
   [Google Scholar]
8. Gao S. J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C. R., Saah A., Phair J., Detels R., Chang Y., Moore P. S. 1996; KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nature Medicine 2:925–928
   [Google Scholar]
9. Haque M., Chen J., Ueda K., Mori Y., Nakano K., Hirata Y., Kanamori S., Uchiyama Y., Inagi R., Okuno T., Yamanishi K. 2000; Identification and analysis of the K5 gene of Kaposi’s sarcoma-associated herpesvirus. Journal of Virology 74:2867–2875
   [Google Scholar]
10. Ishido S., Wang C., Lee B.-S., Cohen G. B., Jung J. U. 2000; Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins. Journal of Virology 74:5300–5309
    [Google Scholar]
11. Jennings S. R., Rice P. L., Kloszewski E. D., Anderson R. W., Thompson D. L., Tevethia S. S. 1985; Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. Journal of Virology 56:757–766
    [Google Scholar]
12. Jones T. R., Wiertz E. J. H. J., Fish K. N., Nelson J. A., Ploegh D. L. 1996; Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proceedings of the National Academy of Sciences, USA 93:11327–11333
    [Google Scholar]
13. Lehner P. J., Karttunen J. T., Wilkinson G. W. G., Cresswell P. 1997; The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proceedings of the National Academy of Sciences, USA 94:6904–6909
    [Google Scholar]
14. Miller G., Rigsby M. O., Heston L., Grogan E., Sun R., Metroka C., Levy J. A., Gao S. J., Chang Y., Moore P. 1996; Antibodies to butyrate-inducible antigens of Kaposi’s sarcoma-associated herpesvirus in patients with HIV-1 infection. New England Journal of Medicine 334:1292–1297
    [Google Scholar]
15. Miller G., Heston L., Grogan E., Gradoville L., Rigsby M., Sun R., Shedd D., Kushnaryov V. M., Grossberg S., Chang Y. 1997; Selective switch between latency and lytic replication of Kaposi’s sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. Journal of Virology 71:314–324
    [Google Scholar]
16. Moore P. S., Gao S. J., Dominguez G., Cesarman E., Lungu O., Knowles D. M., Garber R., McGeoch D. J., Pellet P., Chang Y. 1996; Primary characterization of a herpesvirus-like agent associated with Kaposi’s sarcoma. Journal of Virology 70:549–558
    [Google Scholar]
17. Parravicini C., Chandran B., Corbellino M., Berti E., Paulli M., Moore P. S., Chang Y. 2000; Differential viral protein expression in Kaposi’s sarcoma-associated herpesvirus-infected diseases: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. American Journal of Pathology 156:743–749
    [Google Scholar]
18. Ploegh H. L. 1998; Viral strategies of immune evasion. Science 280:248–253
    [Google Scholar]
19. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. 1996; Lytic growth of Kaposi’s sarcoma associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 2:342–346
    [Google Scholar]
20. Schwartz O., Marechal V., Gall S. L., Lemonnier F., Heard J.-M. 1996; Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 2:338–342
    [Google Scholar]
21. Simpson G. R., Schulz T. F., Whitby D., Cook P. M., Boshoff C., Rainbow L., Howard M. R., Gao S. J., Bohenzky R. A., Simmonds P., Lee C., de Ruiter A., Hatzakis A., Tedder R. S., Weller I. V., Weiss R. A., Moore P. S. 1996; Prevalence of Kaposi’s associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133–1138
    [Google Scholar]
22. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazalas-Hatem D., Babinet P., d’Agay M. F., Clauvel J. P., Raphael M., Degos L., Sigaux F. 1995; Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86:1276–1280
    [Google Scholar]
23. Wiertz E. J. H. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. 1996; The human cytomegalovirus US 11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769–779
    [Google Scholar]